BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35100591)

  • 1. APOL1 Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study.
    Chaudhary NS; Tiwari HK; Hidalgo BA; Limdi NA; Reynolds RJ; Cushman M; Zakai NA; Lange L; Judd SE; Winkler CA; Kopp JB; Gutiérrez OM; Irvin MR
    Am J Nephrol; 2022; 53(2-3):182-190. PubMed ID: 35100591
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study.
    Chen TK; Coresh J; Daya N; Ballew SH; Tin A; Crews DC; Grams ME
    J Am Geriatr Soc; 2021 Jan; 69(1):155-163. PubMed ID: 32894582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.
    Tin A; Grams ME; Estrella M; Lipkowitz M; Greene TH; Kao WHL; Li L; Appel LJ
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1353-1359. PubMed ID: 27230965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
    Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
    J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
    Gutiérrez OM; Irvin MR; Zakai NA; Naik RP; Chaudhary NS; Estrella MM; Limou S; Judd SE; Cushman M; Kopp JB; Winkler CA
    Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary Patterns, Apolipoprotein L1 Risk Genotypes, and CKD Outcomes Among Black Adults in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study.
    Ilori TO; Brooks MS; Desai PN; Cheung KL; Judd SE; Crews DC; Cushman M; Winkler CA; Shlipak MG; Kopp JB; Naik RP; Estrella MM; Gutiérrez OM; Kramer H
    Kidney Med; 2023 May; 5(5):100621. PubMed ID: 37229446
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Young BA; Wilson JG; Reiner A; Kestenbaum B; Franceschini N; Bansal N; Correa A; Himmelfarb J; Katz R
    Kidney Med; 2021; 3(6):962-973.e1. PubMed ID: 34939005
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chaudhary NS; Moore JX; Zakai NA; Judd SE; Naik RP; Limou S; Cushman M; Lange LA; Wang HE; Winkler CA; Irvin MR; Kopp JB; Gutiérrez OM
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1733-1740. PubMed ID: 31704668
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Gutiérrez OM; Irvin MR; Chaudhary NS; Cushman M; Zakai NA; David VA; Limou S; Pamir N; Reiner AP; Naik RP; Sale MM; Safford MM; Hyacinth HI; Judd SE; Kopp JB; Winkler CA
    Circ Genom Precis Med; 2018 Jun; 11(6):e002098. PubMed ID: 29899045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
    Nadkarni GN; Chauhan K; Verghese DA; Parikh CR; Do R; Horowitz CR; Bottinger EP; Coca SG
    Kidney Int; 2018 Jun; 93(6):1409-1416. PubMed ID: 29685497
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Chaudhary NS; Armstrong ND; Hidalgo BA; Gutiérrez OM; Hellwege JN; Limdi NA; Reynolds RJ; Judd SE; Nadkarni GN; Lange L; Winkler CA; Kopp JB; Arnett DK; Tiwari HK; Irvin MR
    Front Med (Lausanne); 2022; 9():971297. PubMed ID: 36250097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants of
    Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Harber M; Santana-Suarez B; Campbell L; Fox J; Ustianowski A; Cosgrove C; Burns JE; Clarke A; Price DA; Chadwick D; Onyango D; Hamzah L; Bramham K; Sabin CA; Winkler CA; Post FA;
    Kidney Int Rep; 2022 Apr; 7(4):786-796. PubMed ID: 35497797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
    Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
    Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.
    Luo S; Coresh J; Tin A; Rebholz CM; Chen TK; Hayek SS; Tracy M; Lipkowitz MS; Appel LJ; Levey AS; Inker LA; Reiser J; Grams ME
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):1013-1021. PubMed ID: 29903900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black and White Adults With CKD Hospitalized With Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Muiru AN; Yang J; Derebail VK; Liu KD; Feldman HI; Srivastava A; Bhat Z; Saraf SL; Chen TK; He J; Estrella MM; Go AS; Hsu CY;
    Am J Kidney Dis; 2022 Nov; 80(5):610-618.e1. PubMed ID: 35405207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women.
    Franceschini N; Kopp JB; Barac A; Martin LW; Li Y; Qian H; Reiner AP; Pollak M; Wallace RB; Rosamond WD; Winkler CA
    JAMA Cardiol; 2018 Aug; 3(8):712-720. PubMed ID: 29971324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype.
    Chen DP; Henderson CD; Anguiano J; Aiello CP; Collie MM; Moreno V; Hu Y; Hogan SL; Falk RJ;
    Clin J Am Soc Nephrol; 2023 Mar; 18(3):337-343. PubMed ID: 36763808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.